Navigation Links
Hyperactivity Drug Can Be Added to Food

According to a small study at the University of Texas, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD) may be safely taken in powder form without compromising any of its beneficial effects.

According to researchers, Metadate, a once-daily treatment for ADHD, may be taken by sprinkling the contents of the capsule onto food.// And because the drug provides a day's worth of medication, children taking Metadate can avoid the social stigma of leaving the classroom to take medication.

The findings are good news for the millions of people who have trouble swallowing pills or capsules, particularly children. An estimated 4% to 12% of school-age children experience ADHD, a disorder marked by impulsiveness, difficulty with academic and social functioning and short attention span. ADHD is commonly treated with the stimulant drug methylphenidate (Ritalin), the active ingredient in Metadate.

The researchers report their findings in the April issue of the Journal of the American Academy of Child and Adolescent Psychiatry. "A controlled-delivery form of methylphenidate...that can be administered once daily and sprinkled on food could help improve compliance in those children who have difficulty swallowing solid dosage forms," Dr. Roy D. Simmons from Rochester, New York-based Celltech Pharmaceuticals, which manufactures Metadate, and colleagues conclude.

In the study, 26 healthy adults without ADHD fasted for 10 hours and then swallowed a Metadate CD capsule or took the medication, containing 20 milligrams of the drug, sprinkled over 1 tablespoon of applesauce. After 6 days of taking no medication, the study volunteers switched treatments.

The researchers took blood samples before volunteers took the medication and again every half-hour to 4 hours over a 24-hour period to measure blood concentrations of the drug. Blood levels were similar for the two treatments and there were no significant d
'"/>




Page: 1 2

Related medicine news :

1. Hyperactivity disorder a biological malfunction
2. Iron Supplementation Aid In Relief From Attention-Deficit/Hyperactivity Disorder
3. Premature, Low Birthweight Babies are Prone to Hyperactivity Disorder
4. Optical Imaging Added To Ultrasound To Improve Imaging Of Breast Cancer
5. Breastfeeding Provides Added Protection To Babies
6. Safety Measures Pose an Added Expenditure for the Airlines
7. Laryngeal Cancer Added to Asbestos’ Crime Lis
8. Added Stress To Pregnant Mothers From Pre-Scan Warnings
9. Ban Added Trans Fatty Acids
10. Activity Added to Video Games can Fight Fat, Shows Mayo Clinic
11. Exercising With Peers Has Added Appeal
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hyperactivity Drug Can Added Food

(Date:5/16/2008)...ndraiser Seeks to Raise $38 Million for Life-threa...-USNewswire/ -- Walkers in nearly,every state will...ay 17 and,18 -- by participating in GREAT STRIDES,...ibrosis Foundation announced today., May is Natio...is is a,life-threatening genetic disease that caus...
(Date:5/16/2008)...etermine who would benefit most from chemo after s...ealthDay News) -- A panel of 15 genes may help det...ell lung cancer will experience a recurrence and, ...ew study shows. , By extension, the same genet...aggressive forms of the cancer who would be able t...
(Date:5/16/2008)... Funds Focus on Millions of Children Still in Dang...d for UNICEF and The,Advertising Council today ann...eries of national public service announcements (PS...iller, Nicole Ritchie, Joel Madden, David,Duchovny...urvivors of the,Myanmar cyclone. The Ad Council is...
(Date:5/16/2008)...ghlights:, - 2007 Comprehensive Income increased ... to $15.9 million, - 2007 Gross Margin of 76%, -...sed 410% to $12.2 million from $2.4 million as ...nhua-PRNewswire-FirstCall/ -- Huiheng,Medical, Inc...: HHGM), a,China-based leader in the development, ...
Breaking Medicine News(10 mins):Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 3Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 4Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 5Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 6
...n University said that an increased glucose level ...es and recall old ones. But on the other hand heal... which have increased sugar levels. A group of ps...h in glucose content has found to increase memory ...
...y, University of Michigan Medical School has repor...in is responsible for producing hypersensitive imm...e protein Cryopyrin is activated by the bacteria a...une response by activating IL-1 beta, which produc...
...any terminally ill cancer patients in the UK are m...ide over financial difficulties related to their t...three quarters of cancer patients are not aware of... This means that they are missing out on ?200 mil...
...ienced by people who had undergone various traumat...ple suffer from recurrences of these bad memories ...se a lot of disturbance in one’s life. Hence resea...ld erase all the bad memories or atleast reduce th...
Other Medicine News:Health News:Post Traumatic Stress Disorder Can Be Prevented? 2
(Date:5/15/2008)... WOODCLIFF LAKE, N.J., May 15 /-...y that results from 16 clinical data abstracts abo...roduct portfolio and,preclinical oncology research...nnual Meeting of the American Society of Clinical ...30 to June 3, 2008., A wide variety of abstracts ...
(Date:5/15/2008)... - Safety and Efficacy Clinical Data from Prosta... Cancers -, - Company to Hold Investor Even...SAN FRANCISCO, Calif., May 15 /PRNewswire-FirstCal... ), a biopharmaceutical company focused,on oncolog...ata from three,clinical trials of picoplatin, in v...
(Date:5/15/2008)... KENILWORTH, N.J., May 15 /PRNewswire-FirstCa...a leader in advancing the science and treatment of...ced today that data from,several clinical studies ...ETOL(R) (ribavirin, USP) combination therapy, as w...ral HCV protease inhibitor, will be presented at,t...
(Date:5/15/2008)... ANN ARBOR, Mich. and TOULOUSE, France, May 1...), a privately held pharmaceutical company,develop...diovascular and,metabolic diseases, today announce...or CER-002, one of the company,s lead product cand...ated receptor (PPAR),delta-specific agonist in dev...
Breaking Medicine Technology:Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Memory tasks require more coordinated brain blood flow for people with high blood pressure 2262 1Memory tasks require more coordinated brain blood flow for people with high blood pressure 2262 2Memory tasks require more coordinated brain blood flow for people with high blood pressure 2262 3New southernpeas developed by ARS cooperators 599 1New southernpeas developed by ARS cooperators 599 2Genes Might Predispose Antidepressant Users to Suicidal Thoughts 2261 1Genes Might Predispose Antidepressant Users to Suicidal Thoughts 2261 2Genes Might Predispose Antidepressant Users to Suicidal Thoughts 2261 3Statement of DePuy Orthopaedics Inc Regarding Agreement with U S Attorneys Office 2258 1Statement of DePuy Orthopaedics Inc Regarding Agreement with U S Attorneys Office 2258 2
... Patients Using ROX-888 Required Significantly Les...n Track To File NDA In 2008, MENLO PARK, CA (June ... ROX-888, its novel intranasal,analgesic, rapidly ...by patients who had undergone major abdominal surg...s our second and final Phase 3 clinical study," sa...
... VALLEY COTTAGE, New York, June 06, 2007 /PRNewsw...unced today that it has,completed the analysis of ...5 in patients with chronic Hepatitis C. This Phase...e escalating study,which evaluated the safety, to...ltiple doses of XTL-2125. The study enrolled 56,pa...
Other Medicine Technology:Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well,Tolerated in Phase 3 Study 2XTL Provides Update on Phase I Clinical Trial of XTL-2125 2XTL Provides Update on Phase I Clinical Trial of XTL-2125 3
The SoftTech Health Lab QMS (Quality Management System) is the first full-featured quality management system built specifically for healthcare labs. The Lab QMS was designed to help you meet quality
...er use both controlled temperature and agitation t...he safety of your plasma. The DH4 (4 bag) and DH8 ...controls that will accommodate a variety of bag co...o operate, allowing you to load, program, and walk...
Conventional Digitally-Controlled Water Baths
... group pf viruses. This virus is found commonly th... the sudden onset of fever, headache, pain in the ...h and retrobulbar pain.,This test is intended for ...i-Dengue IgM antibodies. The Bio-Quant,Dengue IgM ...
Medicine Products: